← The Wire
CRBUNasdaq
Caribou Biosciences, Inc.
Biological Products, (No Diagnostic Substances) · DE · CIK 1619856
Develops transformative allogeneic CAR-T cell therapies for devastating diseases using novel genome-editing technology
$158M
Market cap
$1.77
Last close
+5.4%
1D
+7.9%
5D
2.8M
Volume
Price · last 39 sessions-7.3%
May 4L $1.57 · H $2.43Jun 29
125
Total filings
Jun 18, 2026
Last filing
12/31
Fiscal year end
SC 13GSC 13GNov 14, 2024SC 13GCARIBOU BIOSCIENCES, INC.Feb 23, 2024SC 13GSC 13GJan 8, 2024SC 13GCARIBOU BIOSCIENCES, INC.Jul 20, 2023SC 13GSC 13GFeb 3, 2023SC 13GSC 13GFeb 3, 2023SC 13GSC 13GAug 6, 2021SC 13GSC 13GAug 3, 2021SC 13GSC 13GJul 29, 2021SC 13GSCHEDULE 13GFeb 28, 2017
Insider Activity
In the 90 days to Feb 25, 2026: 4 sold $47K.
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 25, 2026 | Kelly Timothy PChief Technology Officer | Sell | 6,228 | $1.93 | $12K |
| Feb 24, 2026 | Mcclung Barbara GChief Legal Officer | Sell | 6,938 | $1.96 | $14K |
| Feb 24, 2026 | Khan Ruhi AhmadChief Business Officer | Sell | 6,938 | $1.96 | $14K |
| Feb 24, 2026 | Kelly Timothy PChief Technology Officer | Sell | 3,147 | $1.96 | $6K |
| Feb 24, 2026 | Albertson Tina M.Chief Medical Officer | Sell | 1,066 | $1.96 | $2K |
Open-market buys & sells (Form 4, transaction codes P/S). Source: SEC structured insider data.
Similar companies
Comparable business profile · signals at a glance